Pelabresib,Ruxolitinib
morphosys
['#myelof', '$mor', 'morphosys']
#morphosys presents multiple analyses of the #manifest phase 2 trial investigating the potential of #pelabresib in the treatment of #myelofibrosis at #eha22 $mor 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.